Senior insider sale
Chief Executive Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$83.0K
12.50K shares
What this filing means
TOWNSEND RICHARD NOLAN plans to sell 12.50K shares of LEXEO THERAPEUTICS, INC. valued at approximately $83.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001959173-26-001161
DirectorOfficer· Chief Executive Officer
Since Feb 2026
12.50K
Shares to sell
$83.0K
Approx. market value
11.37K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/17/2026
11.37KTotal acquired11.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Restricted Stock Vesting Compensation | 11.37K | — |
| Total | 11.37K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.13K
Market value
$10.5K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.37K
Market value
$72.6K
2/18/2026
Total
Units
12.50K
Value
$83.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/18/2025 | 1.13K | $10.5K | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 11.37K | $72.6K | NASDAQ | Planned |
| Total | 12.50K | $83.0K | ||